{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T21:59:52Z","timestamp":1771970392519,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T00:00:00Z","timestamp":1105660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00431-004-1610-y","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T09:43:10Z","timestamp":1105609390000},"page":"271-276","source":"Crossref","is-referenced-by-count":54,"title":["Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children"],"prefix":"10.1007","volume":"164","author":[{"given":"Ana Mar\ufffda","family":"S\ufffdnchez Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Munoz Muniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Madero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clementina","family":"Borque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\ufffda Jes\ufffds","family":"Garc\ufffda-Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\ufffda Isabel","family":"De Jos\ufffd G\ufffdmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,14]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200205000-00011","volume":"21","author":"Amaya","year":"2002","unstructured":"Amaya R, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW (2002) Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J 21: 405?410","journal-title":"Pediatr Infect Dis J"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1097\/00002030-199911120-00020","volume":"13","author":"Arpadi","year":"1999","unstructured":"Arpadi SM, Cuff P, Horlick MN, Kotler DP (1999) Visceral obesity, hypertriglyceridemia and hypercortisolism in a boy with perinatally acquired HIV infection receiving protease inhibitor-containing antiviral treatment. AIDS 13: 2312?2313","journal-title":"AIDS"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00126334-200105010-00005","volume":"27","author":"Arpadi","year":"2001","unstructured":"Arpadi SM, Cuff PA, Horlick M, Wang J, Kotler DP (2001) Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ lymphocyte count and CD4+ lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acquir Immune Defic Syndr 27: 30?34","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(98)05754-7","volume":"353","author":"Babl","year":"1999","unstructured":"Babl FE, Regan AM, Pelton SI (1999) Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals. Lancet 353: 1243?1244","journal-title":"Lancet"},{"key":"CR5","first-page":"130","volume":"25","author":"Benson","year":"2000","unstructured":"Benson J, Mc Ghee K, Coplan P, Grundfeld C, Robertson M, Brodovicz KG, Slater E (2000) Fat redistribution in indinavir treated patients with HIV infection: a review of postmarketing cases. J AIDS 25: 130?139","journal-title":"J AIDS"},{"key":"CR6","first-page":"463","volume":"22","author":"Bockhorst","year":"2003","unstructured":"Bockhorst JL, Ksseiry I, Toye M, Chipkin SR, Stechenberg BW, Fisher DJ (2003) Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors. Pediatr Infect Dis J 22: 463?465","journal-title":"Pediatr Infect Dis J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1097\/00002030-200112070-00009","volume":"15","author":"Brambilla","year":"2001","unstructured":"Brambilla P, Bricalli D, Sala N, Renzetti F, Manzoni P, Vanzulli A, Chiumello G, Di Natale B, Vigano A (2001) Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS 15: 2415?2422","journal-title":"AIDS"},{"key":"CR8","unstructured":"C\u00e1noves L (2002) Psicopatolog\u00edas en el s\u00edndrome de lipodistrofia. In: Polo Rodrigez R (ed) Manual de nutrici\u00f3n y SIDA. Nilo, Madrid, pp 586?605"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(05)77775-8","volume":"351","author":"Carr","year":"1998","unstructured":"Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Abnormal fat distribution and use of protease inhibitors. Lancet 351: 1736","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51?F58","journal-title":"AIDS"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA (1999) Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353: 2093?2099","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"Carr","year":"2003","unstructured":"Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG (2003) An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 361: 726?735","journal-title":"Lancet"},{"key":"CR13","first-page":"1","volume":"43","author":"Centers","year":"1994","unstructured":"Centers for Disease Control and Prevention (1994) Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43: 1?10","journal-title":"MMWR"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/bies.1152","volume":"23","author":"Cossarizza","year":"2001","unstructured":"Cossarizza A, Mussini C, Vigano A (2001) Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders? Bioessays 23: 1070?1080","journal-title":"Bioessays"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/338564","volume":"185","author":"Cossarizza","year":"2001","unstructured":"Cossarizza A, Pinti M, Moretti L, Bricalli D, Bianchi R, Troiano L, Fernandez MG, Balli F, Brambilla P, Mussini C, Vigano A (2001) Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. J Infect Dis 185: 299?305","journal-title":"J Infect Dis"},{"key":"CR16","first-page":"18","volume":"16","author":"Cossarizza","year":"2002","unstructured":"Cossarizza A, Troiano L, Mussini C (2002) Mitochondria and HIV infection: the first decade. J Biol Regul Homeost Agents 16: 18?24","journal-title":"J Biol Regul Homeost Agents"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","volume":"18","author":"European","year":"2004","unstructured":"European Paediatric Lipodystrophy Group (2004) Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 18: 1443?1451","journal-title":"AIDS"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00126334-200309010-00008","volume":"34","author":"Galli","year":"2003","unstructured":"Galli M, Veglia F, Angarano G, Santambrogio S, Meneghini E, Gritti F (2003) Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at high risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 34: 58?61","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","volume":"32","author":"Hadigan","year":"2001","unstructured":"Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, Davis B, Sax P, Stanley T, Wilson PW, D?Agostino RB, Grinspoon S (2001) Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 32: 130?139","journal-title":"Clin Infect Dis"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","volume":"14","author":"Jaquet","year":"2000","unstructured":"Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, Levy-Marchal C (2000) Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 14: 2123?2128","journal-title":"AIDS"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00006454-200301000-00018","volume":"22","author":"Leonard","year":"2003","unstructured":"Leonard EG, McComsey GA (2003) Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J 22: 77?84","journal-title":"Pediatr Infect Dis J"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00001432-199902000-00003","volume":"12","author":"Martinez","year":"1999","unstructured":"Martinez E, Gatell JM (1999) Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: the lipodystrophy syndrome. Curr Opin Infect Dis 12: 13?19","journal-title":"Curr Opin Infect Dis"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(00)02850-6","volume":"356","author":"Martinez","year":"2000","unstructured":"Martinez E, Bianchi L, Garc\u00eda-Viejo MA, Bru C, Gatell JM (2000) Sonographic assessment of regional fat in HIV-infected persons. Lancet 356: 1412?1413","journal-title":"Lancet"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00002018-200124030-00001","volume":"24","author":"Martinez","year":"2001","unstructured":"Martinez E, Garc\u00eda-Viejo MA, Blanch J, Gatell JM (2001) Lipodystrophy syndrome in patients with HIV infection:quality of life issues. Drug Safety 24: 157?166","journal-title":"Drug Safety"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","volume":"357","author":"Martinez","year":"2001","unstructured":"Martinez E, Mocroft A, Garc\u00eda-Viejo MA, P\u00e9rez-Cuevas JB, Blanco JL, Mallolas J, Bianchi L, Conget I, Blanch J, Philips A, Gatell JM (2001) Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: a prospective cohort study. Lancet 357: 592?598","journal-title":"Lancet"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1542\/peds.111.3.e275","volume":"111","author":"McComsey","year":"2003","unstructured":"McComsey G, B.N, Ma Jen-Fu, Rathore M, Alvarez A (2003) Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the first pediatric switch study. Pediatrics 111: 275?281","journal-title":"Pediatrics"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200409030-00004","volume":"18","author":"McComsey","year":"2004","unstructured":"McComsey G, Leonard E (2004) Metabolic complications of HIV therapy in children. AIDS 18: 1753?1768","journal-title":"AIDS"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S0029665100000185","volume":"59","author":"Miller","year":"2000","unstructured":"Miller TL (2000) Nutrition in paediatric human immunodeficiency virus infection. Proc Nutr Soc 59: 155?162","journal-title":"Proc Nutr Soc"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00002030-200109280-00011","volume":"15","author":"Mora","year":"2001","unstructured":"Mora S, Sala N, Bricalli D, Zuin G, Chiumello G, Vigano A (2001) Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy. AIDS 15: 1823?1829","journal-title":"AIDS"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2001.tb03914.x","volume":"946","author":"Narciso","year":"2001","unstructured":"Narciso P, Tozzi V, D?Offizi G, De Carli G, Orchi N, Galati V, Vincenzi L, Bellagamba R, Carvelli C, Puro V (2001) Metabolic and morphologic disorders in patients treated with highly active antiretroviral therapy since primary HIV infection. Ann N Y Acad Sci 946: 214?222","journal-title":"Ann N Y Acad Sci"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00002030-200104130-00008","volume":"15","author":"Pernerstorfer-Schoen","year":"2001","unstructured":"Pernerstorfer-Schoen H, Jilma B, Perschler A, Wichlas S, Schindler K, Schindl A (2001) Sex differences in HAART-associated dyslipidaemia. AIDS 15: 725?734","journal-title":"AIDS"},{"key":"CR32","unstructured":"Polo Rodriguez R (2002) Manual de Nutrici\u00f3n y SIDA, 3rd edn. Nilo, Madrid"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","volume":"14","author":"Saint-Marc","year":"2002","unstructured":"Saint-Marc T, Poizot-Martin I, Bruno F, Rouviere O, Lang JM, Gastaut JA, Touraine JL (2002) Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 14: 37?49","journal-title":"AIDS"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ajcn\/51.6.953","volume":"51","author":"Seidell","year":"1990","unstructured":"Seidell JC, van der Kooy K (1990) Imaging techniques for measuring adipose tissue distribution: a comparison between computed tomography and 1.5\u00a0T magnetic resonance. Am J Clin Nutr 51: 953?957","journal-title":"Am J Clin Nutr"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(02)00183-4","volume":"2","author":"Van","year":"2002","unstructured":"Van Rossum AM, Fraaij JP, de Groot R (2002) Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect Dis 2: 93?102","journal-title":"Lancet Infect Dis"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1592\/phco.21.9.861.34555","volume":"21","author":"Wedekind","year":"2001","unstructured":"Wedekind CA, Pugatch D (2001) Lipodystrophy syndrome in children infected with human immunodeficiency virus. Pharmacotherapy 21: 861?866","journal-title":"Pharmacotherapy"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1148\/radiology.211.1.r99ap15283","volume":"211","author":"Yoshizumi","year":"1999","unstructured":"Yoshizumi T, Nakamura T, Yamane N, Islam AH, Menju M, Yamasaki K, Arai T, Kotami K, Funahashi T, Yamashita S, Matsuzawa Y (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211: 283?286","journal-title":"Radiology"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-004-1610-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-004-1610-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-004-1610-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:21:01Z","timestamp":1559082061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-004-1610-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,14]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1610"],"URL":"https:\/\/doi.org\/10.1007\/s00431-004-1610-y","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,14]]}}}